Sign In
Create Account
Forgot Password?
Save
esh.org
ESH Featured
Specific Diseases
Covered Events
All Materials
Contributors
Archives
Document Library
Open Access
Search
Loading
Navbar input
WAIT FOR SUGGESTIONS BY CATEGORY
OR CONTINUE TYPING IN YOUR KEYWORDS
ENTER ONE OR MULTIPLE KEYWORDS &
PRESS THE SEARCH BUTTON
From
To
Search
Favorites
Advanced
Minimize
Clear
Protected by US Patents
For full functionality of this site it is necessary to enable JavaScript. Here are the
instructions how to enable JavaScript in your web browser
.
SATELLITE SYMPOSIUM: Quality of life for patients with CML: Where are we now?
ESH eLearning, Faculty / Presenters, 4145898
What is the goal of CML therapy? A physician’s impression of a patient’s impression and are we (the physicians) missing the boat?
ESH eLearning, Jeffrey Lipton, 4145897
Selected Abstract: Bone marrow common lymphoid progenitors and B cell subsets as predictors of treatment-free remission in CML
ESH eLearning, Shaun Patterson, 4145896
Keynote Presentation: Role of the immune system in CML: does it matter and how?
ESH eLearning, Agnes Yong, 4145893
Leukemic stem cells and the bone marrow microenvironment: Friend or foe?
ESH eLearning, Dominique Bonnet, 4145892
A randomized trial of the addition of ruxolitinib to BCR::ABL1 tyrosine kinase inhibitors (TKIs) for patients with chronic myeloid leukemia (CML) with molecular evidence of disease (SWOG trial S1712)
ESH eLearning, Kendra Sweet, 4145890
The negative impact of variants in blood-cancer related genes for frontline imatinib treated patients is not overcome by frontline treatment with more potent BCR::ABL1 inhibitors
ESH eLearning, Susan Branford, 4145889
BNIP3 is required for hypoxia-induced reductive glutamine carboxylation in leukaemic cells
ESH eLearning, Daniele Sarnello, 4145888
Welcome
ESH eLearning, Jorge Cortes, 4145885
Conference Book (PDF)
ESH eLearning, Faculty / Presenters, 4145884
Automated, point-of-care manufacturing
ESH eLearning, Halvard Bönig, 4145833
Application of AI and machine learning
ESH eLearning, Dominic Grün, 4145832
Regeneration/rejuvenation of immune cells
ESH eLearning, Stephen Gottschalk, 4145831
Overcoming T cell exhaustion and tumor resistance
ESH eLearning, Marco Ruella, 4145829
Harnessing the immune suppressive microenvironment in gastrointestinal tumors
ESH eLearning, Alessia Potenza, 4145828
Analyses on tumor and TME
ESH eLearning, Leo Rasche, 4145825
Host factors: Microbiome
ESH eLearning, Maik Luu, 4145824
Analyses on products before and after infusion
ESH eLearning, Marcela Maus, 4145823
Nanoparticle technology
ESH eLearning, Jennifer E. Adair, 4145821
Targeted viral vectors
ESH eLearning, Christian Buchholz, 4145820
B cells for humoral immunity
ESH eLearning, Adi Barzel, 4145819
NK cells
ESH eLearning, Michael O'Dwyer, 4145816
iPSC-derived cells
ESH eLearning, Shin Kaneko, 4145815
NKT cell
ESH eLearning, Giulia Casorati, 4145814
Safety-validating and enhancing CRISPR 2.0 to improve immune cell therapies
ESH eLearning, Karl Petri, 4145812
Targeted CAR & TCR gene insertion
ESH eLearning, Dirk Busch, 4145811
Understanding T-Cell antigen recognition: from fundamental insights to clinical applications
ESH eLearning, Johannes Huppa, 4145808
Modular and Programmable Drug-On CAR Designs
ESH eLearning, Michael Jensen, 4145807
TCR & TCR-like
ESH eLearning, Chiara Bonini, 4145806
TCR targets
ESH eLearning, Aude Chapuis, 4145803
Clinicial managment
ESH eLearning, Larry Bacon, 4145800
Autoimmune diseases
ESH eLearning, Matteo Doglio, 4145799
Hematology
ESH eLearning, Claire Roddie, 4145798
Conference Book (PDF)
ESH eLearning, Faculty / Presenters, 4145759
Meeting Highlights: Interview of Professor Grant Challen during #ESHMPN2024
ESH eLearning, Grant Challen, 4147811
Meeting Highlights: Interview of Professor Tony Green during #ESHMPN2024
ESH eLearning, Tony Green, 4147810
Meeting Highlights: Interview of Professor Ann Mullaly during #ESHMPN2024
ESH eLearning, Ann Mullally, 4147809
Closing Remarks
ESH eLearning, Faculty / Presenters, 417862
Panel discussion
ESH eLearning, Faculty / Presenters, 417861
Future therapies for PV and ET
ESH eLearning, Claire Harrison, 417860
Biology and clinical long-term outcome of JAK2-neg erythrocytosis
ESH eLearning, Stephane Giraudier, 417859
Diagnosis and genetics of congenital erythrocytosis
ESH eLearning, Betty Gardie, 417858
Panel discussion
ESH eLearning, Faculty / Presenters, 417857
Mutant CALR as a therapeutic target
ESH eLearning, Isabelle Plo, 417856
Pathogenicity and dependencies between mtCALR and MPL
ESH eLearning, Edwin CHEN, 417855
Mechanisms of transformation by CALR mutation
ESH eLearning, Shannon Elf, 417854
Panel discussion
ESH eLearning, Faculty / Presenters, 417853
MPN/MDS overlap: new criteria and current management
ESH eLearning, Lionel ADES, 417852
Machine learning for MPN diagnostics
ESH eLearning, Dan ROYSTON, 417851
Real world investigation and diagnosis of triple negative thrombocytosis
ESH eLearning, Anna Godfrey, 417850
Panel discussion
ESH eLearning, Faculty / Presenters, 417849
Novel MPN Therapeutics
ESH eLearning, Ross Levine, 417848
Advances and remaining gaps in the treatment of MPNs
ESH eLearning, Ruben Mesa, 417847
Panel discussion
ESH eLearning, Faculty / Presenters, 417846
How to recognize and manage ruxolitinib treatment failure?
ESH eLearning, Alessandro Vannucchi, 417844
Novel Therapies for High Risk MPN
ESH eLearning, Prithviraj Bose, 417843
Panel discussion
ESH eLearning, Faculty / Presenters, 417841
The conundrum of TP53 mutations in MPN
ESH eLearning, Ann Mullally, 417840
Immunothrombosis: a major actor of MPN-associated thrombosis
ESH eLearning, Chloe James, 417839
Novel approaches to modeling MPN
ESH eLearning, Grant Challen, 417838
Ex vivo modeling of MPN
ESH eLearning, Bethan PSAILA, 417837
Panel discussion
ESH eLearning, Faculty / Presenters, 417836
Mechanisms of leukemic transformation in MPNs
ESH eLearning, Raajit K Rampal, 417835
Molecular pathogenesis to leukaemic transformation
ESH eLearning, Adam Mead, 417834
Prognostic impact of molecular landscape in 428 polycythemia vera from the French MPN database (fimbank)
ESH eLearning, Damien Luque Paz, 417832
Panel discussion
ESH eLearning, Faculty / Presenters, 417831
Targeting iron metabolism in MPN
ESH eLearning, Ronald Hoffman, 417830
Targeting Inflammation in MPN
ESH eLearning, Angela Fleischman, 417829
Panel discussion
ESH eLearning, Faculty / Presenters, 417828
Insights from Genomic Studies of MPN
ESH eLearning, Jyoti Nangalia, 417827
Evolution of clonal hematopoiesis to MPN
ESH eLearning, Gerwin Huls, 417826
Keynote Lecture: MPN pathogenesis - a riddle wrapped in a mystery inside an enigma
ESH eLearning, Anthony Green, 417825
Welcome words
ESH eLearning, Jyoti Nangalia, 417824
Conference Book (PDF)
ESH eLearning, Faculty / Presenters, 417409
US, others
ESH eLearning, Guillermo Garcia-Manero, 412598
German, EMSCO, Italian
ESH eLearning, Faculty / Presenters, 412597
French, Spanish
ESH eLearning, Faculty / Presenters, 412596
Allogeneic HSCT in aged patients
ESH eLearning, Didier Blaise, 412595
Allo HSCT in patients with MDS
ESH eLearning, Didier Blaise, 412594
Response criteria for HR myelodysplastic syndromes
ESH eLearning, Amer M. Zeidan, 412592
Hypomethylating agent combinations
ESH eLearning, Mikkael A. Sekeres, 412591
HMAs -- a party of one
ESH eLearning, Guillermo Garcia-Manero, 412590
Pitfalls of response assessment in MDS
ESH eLearning, Mikkael A. Sekeres, 412589
Defining and treating relapsed/refractory lower-risk myelodysplastic syndromes
ESH eLearning, Valeria Santini, 412588
Standards for managing anemia
ESH eLearning, Eva Hellström- Lindberg, 412587
Frailty in MDS Patients
ESH eLearning, Rena Buckstein, 412586
A role for mature cells of the leukemic clone in chronic myelomonocytic leukemia
ESH eLearning, Dorothée Selimoglu-Buet, 412585
Myelodysplastic syndrome with SF3B1 gene mutation
ESH eLearning, Michaela Fontenay, 412584
The many faces of TP53
ESH eLearning, Claudia Haferlach, 412583
Comparing prognostic schemas
ESH eLearning, Torsten Haferlach, 412582
AI/ML to predict myelodysplastic syndromes response to drugs
ESH eLearning, Jaroslaw Maciejewski, 412581
AI/ML to predict myelodysplastic syndromes prognosis
ESH eLearning, Aziz Nazha, 412580
AI/ML to diagnose myelodysplastic syndromes
ESH eLearning, Carsten Marr, 412579
WHO v. ICC
ESH eLearning, Lionel ADES, 412578
Diagnosing myelodysplastic syndromes: NGS
ESH eLearning, Klaus Metzeler, 412577
Diagnosing myelodysplastic syndromes: Classical tools
ESH eLearning, Aristoteles Giagounidis, 412576
The immunome
ESH eLearning, Shahram KORDASTI, 412573
Therapy related myelodysplastic syndromes
ESH eLearning, Jean-Baptiste Micol, 412572
Germline mutations
ESH eLearning, Marie Sébert, 412571
Clonal haematopoiesis
ESH eLearning, Katharina GÖTZE, 412569
«
1
2
3
4
5
6
7
8
9
10
...
»